Cohen O J, Paolucci S, Bende S M, Daucher M, Moriuchi H, Moriuchi M, Cicala C, Davey R T, Baird B, Fauci A S
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland 20892-1876, USA.
J Virol. 1998 Jul;72(7):6215-7. doi: 10.1128/JVI.72.7.6215-6217.1998.
Polymorphisms in the coding sequences of CCR5 and CXCR4 were studied in a group of human immunodeficiency virus (HIV)-infected long-term nonprogressors. Two different point mutations were found in the CXCR4 coding sequence. One of these CXCR4 mutations was silent, and each was unique to two nonprogressors. The well-described 32-bp deletion within the CCR5 coding sequence (CCR5-Delta32) was found in 4 of 13 nonprogressors, and 12 different point mutations were found scattered over the CCR5 coding sequence from 8 nonprogressors. Most of the mutations created either silent or conservative changes in the predicted amino acid sequence: only one of these mutations was found in more than a single nonprogressor. All nonsilent mutations were tested in an HIV envelope-dependent fusion assay, and all functioned comparably to wild-type controls. Polymorphisms in the CXCR4 and CCR5 coding sequences other than CCR5-Delta32 do not appear to play a dominant mechanistic role in nonprogression among HIV-infected individuals.
在一组感染人类免疫缺陷病毒(HIV)的长期不进展者中,对CCR5和CXCR4编码序列中的多态性进行了研究。在CXCR4编码序列中发现了两种不同的点突变。其中一种CXCR4突变是沉默突变,且每种突变分别为两名不进展者所特有。在13名不进展者中的4名中发现了CCR5编码序列中描述详尽的32碱基对缺失(CCR5-Δ32),并且在8名不进展者的CCR5编码序列中发现了12种不同的点突变散布其中。大多数突变在预测的氨基酸序列中产生了沉默或保守变化:这些突变中只有一种在不止一名不进展者中被发现。所有非同义突变均在HIV包膜依赖性融合试验中进行了测试,并且所有突变的功能与野生型对照相当。除CCR5-Δ32外,CXCR4和CCR5编码序列中的多态性似乎在HIV感染个体的病情不进展中不发挥主要机制作用。